Logo image of NGEN.CA

NERVGEN PHARMA CORP (NGEN.CA) Stock Analyst Earnings Estimates

TSX-V:NGEN - TSX Venture Exchange - CA64082X2032 - Common Stock - Currency: CAD

2.95  -0.02 (-0.67%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Revenue
YoY % growth
EBITDA
YoY % growth
EBIT
YoY % growth
Operating Margin
EPS
YoY % growth

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
NGEN.CA Yearly EPS VS EstimatesNGEN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
NGEN.CA Yearly Revenue VS EstimatesNGEN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 4.6% 1.19%
RevenueN/A N/A N/A N/A